Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05683691 · ClinicalTrials.gov registry record · NA

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

A NA study of Prostate Cancer, sponsored by Francis Medical.

Active
Registry status
NA
Development phase
400
Enrollment target
20
Study locations

NCT05683691 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Francis Medical. The registered enrollment target is 400 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (34% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05683691, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Francis Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • DEVICE Vanquish System

Study Locations (20)

Minnesota

  • University of Minnesota - Minneapolis
  • Mayo Clinic- Rochester - Rochester
  • Minnesota Urology - Woodbury

New York

  • NYU Langone Health - New York
  • Northwell Health- Lenox Hill Hospital - New York
  • University of Rochester - Rochester

California

  • Memorial Care - Laguna Hills
  • University of Southern California - Los Angeles

Maryland

  • Chesapeake Urology - Baltimore
  • Johns Hopkins - Baltimore

Michigan

  • Corewell Health / William Beaumont University Hospital - Royal Oak
  • Michigan Institute of Urology - Troy

Arizona

  • Mayo Clinic- Phoenix - Phoenix

Florida

  • Kasraeian Urology - Jacksonville

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-05-16
Est. Completion 2029-04
Phase NA

Sponsor

Francis Medical

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05683691

The ClinicalTrials.gov registry entry for NCT05683691 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (34% lower). The listed sponsor is Francis Medical, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Vanquish System is the first listed.

NCT05683691 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Minnesota, New York, California.

Frequently Asked Questions

What is clinical trial NCT05683691 about?

NCT05683691 is a clinical study titled "Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer". The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.

What is the current status of trial NCT05683691?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-05-16. Estimated completion is 2029-04.

What conditions does trial NCT05683691 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05683691?

The interventions under investigation include: Vanquish System (DEVICE).

Who is sponsoring clinical trial NCT05683691?

This trial is sponsored by Francis Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05683691 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.